Panbela Therapeutics effects 1-for-20 reverse stock split; shares outstanding drop to 480,244

Panbela Therapeutics, Inc.

Reverse split effective Jan 18, 2024; every 20 shares converted into 1 share.
Post-split estimated shares outstanding: 480,244.
New CUSIP number for common stock is 69833W404.
Proportionate adjustments made to equity awards and warrants.
Number of authorized shares unchanged; no fractional shares issued.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Panbela Therapeutics, Inc.: Filed Certificate of Amendment to Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (effective 2024-01-16).

Change: charter amendment
Effective: 2024-01-16

Exact text from the filing

On January 16, 2024, the Company filed a Certificate of Amendment to the Restated Certificate of Incorporation (the "Amendment") to effect the Reverse Split.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001437749-24-001758

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.